Concepedia

Mingxiang Liao

ML

25

Publications

1K

Citations

20

H-Index

2005

Active since

Affiliations

Takeda (United States)(Current)

University of California, San Francisco

University of Washington

Gilead Sciences (United States)

Biogen (United States)

Mingxiang Liao is an author at Takeda (United States) specializing in medicine, pharmacology, and liver physiology.

ORCID

Top concepts

Publications per year

2005–2023

25

Publications

25

Transporter Expression in Liver Tissue from Subjects with Alcoholic or Hepatitis C Cirrhosis Quantified by Targeted Quantitative Proteomics

C. B. Collins, Edward J. Kelly, Xiaoyan Chu et al. · Drug Metabolism and Disposition · 2016 · 117 citations · Full text

Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics Study

Bhagwat Prasad, Deepak Bhatt, Katherine Johnson et al. · Drug Metabolism and Disposition · 2018 · 88 citations · Full text

CYP3A4-Mediated Carbamazepine (CBZ) Metabolism: Formation of a Covalent CBZ-CYP3A4 Adduct and Alteration of the Enzyme Kinetic Profile

Ping Kang, Mingxiang Liao, Michael R. Wester et al. · Drug Metabolism and Disposition · 2007 · 66 citations · Full text

Positron Emission Tomography Imaging of [<sup>11</sup>C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A

Sarah Billington, Steven C. Shoner, Scott D. Lee et al. · Clinical Pharmacology & Therapeutics · 2019 · 61 citations

Transporter Expression in Noncancerous and Cancerous Liver Tissue from Donors with Hepatocellular Carcinoma and Chronic Hepatitis C Infection Quantified by LC-MS/MS Proteomics

Sarah Billington, Adrian S. Ray, Laurent Salphati et al. · Drug Metabolism and Disposition · 2017 · 60 citations · Full text

Rows per page

1–5 of 25